Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
C-Reactive Protein Testing Market: By Assay Type, By Detection Range, By Disease Area, By End-use and Region
C-Reactive Protein Testing Market size was valued at US$ 2,892.2 million in 2023 and is poised to grow at a significant CAGR of 2.7% from 2024-2030. C-reactive protein testing (CRP), an acute-phase protein produced by the liver, increases in concentration in the blood due to an inflammatory disorder. The CRP test detects the amount of CRP in blood cells. This test identifies various types of infections such as Cardiovascular diseases, Arthritis, Cancer, etc. The increase in the geriatric population globally and the growing prevalence of infectious and chronic diseases such as cancer, diabetes, cardiovascular, and arthritis are some of the primary factors that can propel the growth of the CPR market.
Moreover, lower immunity and shifting toward an inactive lifestyle raise the demand for healthcare services which helps in the growth of the CPR market. Additionally, various initiatives are taken by the government, prominent market players, and non-profit organizations to increase awareness of CPR testing which can further boost the market growth.
Furthermore, the presence of numerous rapid kits and point-of-care devices has promoted the growth of the CPR market. However, a wide variety of alternative disease testing approaches which is more accurate such as an echocardiogram (ultrasound), and electrocardiogram (ECG) for cardiac disease screening can hinder the market CPR growth. CPR testing has the ability to differentiate between pathological and physiological CPR levels which can treat inflammatory illnesses has created lucrative opportunities for new players to enter the market. Nevertheless, increasing healthcare demands and improved healthcare infrastructures have created an attractive opportunity to expand the market size. The key trend in the CPR market is the initiatives taken by the government to encourage the usage of point-of-care testing in healthcare centers which can further support to boost the CPR market.
Study Period
2024-2030Base Year
2023CAGR
2.7%Largest Market
Asia-PacificFastest Growing Market
North America
The global C-reactive protein testing market is primarily driven by an increase in the prevalence of inflammatory diseases. As the number of the aging population is rising globally, and rise in chronic and cardiovascular diseases is observed. Due to this, CPR testing is implemented as a prime diagnostic tool which is expected to increase the market share in the coming next few years. Additionally, rising public and private funding for research and development of CPR are further expected to expand the CRP market globally.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 2,892.2 million |
Market CAGR |
2.7% |
By Assay Type |
|
By Detection Range |
|
By Disease Type |
|
By End User |
|
By Region |
|
Download Free Sample Report
The global c reactive protein testing market size was valued at US$ 2,892.2 million in 2023 and is projected to grow at a CAGR of 2.7% from 2024-2030.
Key players’ profiles in the c-reactive protein testing market report are Thermo Fisher Scientific, inc., F. Hoffmann-La Roche Ltd., Danaher, Quest Diagnostics, Siemens Healthineers AG, Abbott, Merck KGaAA, Zoetis, Ortho Clinical Diagnostics, Getein Biotech.
A rise in the geriatric population, an increase in chronic diseases growing R&D activities in C-reactive protein testing, and government initiatives to promote point-to-care testing which uses CPR testing.
1. Executive Summary |
2. Global C-Reactive Protein Testing Market Introduction |
2.1. Global C-Reactive Protein Testing Market Taxonomy |
2.2. Global C-Reactive Protein Testing Market Definitions |
2.2.1. By Assay Type |
2.2.2. By Detection Range |
2.2.3. By Disease Area |
2.2.4. By End-use |
2.2.5. By Region |
3. Global C-Reactive Protein Testing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global C-Reactive Protein Testing Market Dynamic Factors - Impact Analysis |
3.6. Global C-Reactive Protein Testing Market Competition Landscape |
4. Global C-Reactive Protein Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global C-Reactive Protein Testing Market, By Assay Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1. Immunoturbidimetric Assay |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. ELISA |
5.2.1. Clinical |
5.2.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.1.3. Market Opportunity Analysis |
5.2.2. Non-clinical |
5.2.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.2.3. Market Opportunity Analysis |
5.3. Chemiluminescence Immunoassay |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Others |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6. Global C-Reactive Protein Testing Market, By Detection Range, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1. hs-CRP |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Conventional CRP |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. cCRP |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global C-Reactive Protein Testing Market, By Disease Area, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1. Cardiovascular Diseases |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Cancer |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Rheumatoid Arthritis |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Inflammatory Bowel Disease |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Endometriosis |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Lupus |
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.6.3. Market Opportunity Analysis |
8. Global C-Reactive Protein Testing Market, By End-use, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1. Clinics |
8.1.1. By Entity |
8.1.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.1.3. Market Opportunity Analysis |
8.1.2. By Settings |
8.1.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.2.3. Market Opportunity Analysis |
8.2. Hospitals |
8.2.1. Urban Setting |
8.2.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.1.3. Market Opportunity Analysis |
8.2.2. Rural Setting |
8.2.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.2.3. Market Opportunity Analysis |
8.3. Laboratories |
8.3.1. Urban Setting |
8.3.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.1.3. Market Opportunity Analysis |
8.3.2. Rural Setting |
8.3.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.2.3. Market Opportunity Analysis |
8.4. Assisted Living Healthcare Facilities |
8.4.1. Urban Setting |
8.4.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.1.3. Market Opportunity Analysis |
8.4.2. Rural Setting |
8.4.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.2.3. Market Opportunity Analysis |
8.5. Home |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Others |
8.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.6.3. Market Opportunity Analysis |
9. Global C-Reactive Protein Testing Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia-Pacific |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Latin America |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Middle East and Africa |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Global C-Reactive Protein Testing Market - Opportunity Analysis Index, By Assay Type, By Detection Range, By Disease Area, By End-use, and Region, 2024 - 2030 |
10. North America C-Reactive Protein Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
10.1. Assay Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Immunoturbidimetric Assay |
10.1.2. ELISA |
10.1.2.1. Clinical |
10.1.2.2. Non-clinical |
10.1.3. Chemiluminescence Immunoassay |
10.1.4. Others |
10.2. Detection Range Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. hs-CRP |
10.2.2. Conventional CRP |
10.2.3. cCRP |
10.3. Disease Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Cardiovascular Diseases |
10.3.2. Cancer |
10.3.3. Rheumatoid Arthritis |
10.3.4. Inflammatory Bowel Disease |
10.3.5. Endometriosis |
10.3.6. Lupus |
10.3.7. Others |
10.4. End-use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Clinics |
10.4.1.1. By Entity |
10.4.1.2. By Settings |
10.4.2. Hospitals |
10.4.2.1. Urban Setting |
10.4.2.2. Rural Setting |
10.4.3. Laboratories |
10.4.3.1. Urban Setting |
10.4.3.2. Rural Setting |
10.4.4. Assisted Living Healthcare Facilities |
10.4.4.1. Urban Setting |
10.4.4.2. Rural Setting |
10.4.5. Home |
10.4.6. Others |
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.5.1. USA |
10.5.2. Canada |
10.6. North America C-Reactive Protein Testing Market - Opportunity Analysis Index, By Assay Type, By Detection Range, By Disease Area, By End-use, and Country, 2024 - 2030 |
10.7. North America C-Reactive Protein Testing Market Dynamics Trends |
11. Europe C-Reactive Protein Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
11.1. Assay Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Immunoturbidimetric Assay |
11.1.2. ELISA |
11.1.2.1. Clinical |
11.1.2.2. Non-clinical |
11.1.3. Chemiluminescence Immunoassay |
11.1.4. Others |
11.2. Detection Range Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. hs-CRP |
11.2.2. Conventional CRP |
11.2.3. cCRP |
11.3. Disease Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Cardiovascular Diseases |
11.3.2. Cancer |
11.3.3. Rheumatoid Arthritis |
11.3.4. Inflammatory Bowel Disease |
11.3.5. Endometriosis |
11.3.6. Lupus |
11.3.7. Others |
11.4. End-use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Clinics |
11.4.1.1. By Entity |
11.4.1.2. By Settings |
11.4.2. Hospitals |
11.4.2.1. Urban Setting |
11.4.2.2. Rural Setting |
11.4.3. Laboratories |
11.4.3.1. Urban Setting |
11.4.3.2. Rural Setting |
11.4.4. Assisted Living Healthcare Facilities |
11.4.4.1. Urban Setting |
11.4.4.2. Rural Setting |
11.4.5. Home |
11.4.6. Others |
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Germany |
11.5.2. UK |
11.5.3. France |
11.5.4. Spain |
11.5.5. Italy |
11.5.6. Russia |
11.5.7. Rest of Europe |
11.6. Europe C-Reactive Protein Testing Market - Opportunity Analysis Index, By Assay Type, By Detection Range, By Disease Area, By End-use, and Country, 2024 - 2030 |
11.7. Europe C-Reactive Protein Testing Market Dynamics Trends |
12. Asia-Pacific C-Reactive Protein Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
12.1. Assay Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Immunoturbidimetric Assay |
12.1.2. ELISA |
12.1.2.1. Clinical |
12.1.2.2. Non-clinical |
12.1.3. Chemiluminescence Immunoassay |
12.1.4. Others |
12.2. Detection Range Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. hs-CRP |
12.2.2. Conventional CRP |
12.2.3. cCRP |
12.3. Disease Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Cardiovascular Diseases |
12.3.2. Cancer |
12.3.3. Rheumatoid Arthritis |
12.3.4. Inflammatory Bowel Disease |
12.3.5. Endometriosis |
12.3.6. Lupus |
12.3.7. Others |
12.4. End-use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Clinics |
12.4.1.1. By Entity |
12.4.1.2. By Settings |
12.4.2. Hospitals |
12.4.2.1. Urban Setting |
12.4.2.2. Rural Setting |
12.4.3. Laboratories |
12.4.3.1. Urban Setting |
12.4.3.2. Rural Setting |
12.4.4. Assisted Living Healthcare Facilities |
12.4.4.1. Urban Setting |
12.4.4.2. Rural Setting |
12.4.5. Home |
12.4.6. Others |
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.5.1. China |
12.5.2. India |
12.5.3. Japan |
12.5.4. ASEAN |
12.5.5. Australia & New Zealand |
12.5.6. Rest of Asia-Pacific |
12.6. Asia-Pacific C-Reactive Protein Testing Market - Opportunity Analysis Index, By Assay Type, By Detection Range, By Disease Area, By End-use, and Country, 2024 - 2030 |
12.7. Asia-Pacific C-Reactive Protein Testing Market Dynamics Trends |
13. Latin America C-Reactive Protein Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
13.1. Assay Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Immunoturbidimetric Assay |
13.1.2. ELISA |
13.1.2.1. Clinical |
13.1.2.2. Non-clinical |
13.1.3. Chemiluminescence Immunoassay |
13.1.4. Others |
13.2. Detection Range Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. hs-CRP |
13.2.2. Conventional CRP |
13.2.3. cCRP |
13.3. Disease Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Cardiovascular Diseases |
13.3.2. Cancer |
13.3.3. Rheumatoid Arthritis |
13.3.4. Inflammatory Bowel Disease |
13.3.5. Endometriosis |
13.3.6. Lupus |
13.3.7. Others |
13.4. End-use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Clinics |
13.4.1.1. By Entity |
13.4.1.2. By Settings |
13.4.2. Hospitals |
13.4.2.1. Urban Setting |
13.4.2.2. Rural Setting |
13.4.3. Laboratories |
13.4.3.1. Urban Setting |
13.4.3.2. Rural Setting |
13.4.4. Assisted Living Healthcare Facilities |
13.4.4.1. Urban Setting |
13.4.4.2. Rural Setting |
13.4.5. Home |
13.4.6. Others |
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Brazil |
13.5.2. Mexico |
13.5.3. Rest of Latin America |
13.6. Latin America C-Reactive Protein Testing Market - Opportunity Analysis Index, By Assay Type, By Detection Range, By Disease Area, By End-use, and Country, 2024 - 2030 |
13.7. Latin America C-Reactive Protein Testing Market Dynamics Trends |
14. Middle East and Africa C-Reactive Protein Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
14.1. Assay Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Immunoturbidimetric Assay |
14.1.2. ELISA |
14.1.2.1. Clinical |
14.1.2.2. Non-clinical |
14.1.3. Chemiluminescence Immunoassay |
14.1.4. Others |
14.2. Detection Range Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.2.1. hs-CRP |
14.2.2. Conventional CRP |
14.2.3. cCRP |
14.3. Disease Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Cardiovascular Diseases |
14.3.2. Cancer |
14.3.3. Rheumatoid Arthritis |
14.3.4. Inflammatory Bowel Disease |
14.3.5. Endometriosis |
14.3.6. Lupus |
14.3.7. Others |
14.4. End-use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Clinics |
14.4.1.1. By Entity |
14.4.1.2. By Settings |
14.4.2. Hospitals |
14.4.2.1. Urban Setting |
14.4.2.2. Rural Setting |
14.4.3. Laboratories |
14.4.3.1. Urban Setting |
14.4.3.2. Rural Setting |
14.4.4. Assisted Living Healthcare Facilities |
14.4.4.1. Urban Setting |
14.4.4.2. Rural Setting |
14.4.5. Home |
14.4.6. Others |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Gulf CoEnd-use Council (GCC) Countries |
14.5.2. South Africa |
14.5.3. Rest of MEA |
14.6. MEA C-Reactive Protein Testing Market - Opportunity Analysis Index, By Assay Type, By Detection Range, By Disease Area, By End-use, and Country, 2024 - 2030 |
14.7. MEA C-Reactive Protein Testing Market Dynamics Trends |
15. Competition Landscape |
15.1. Strategic Dashboard of Top Market Players |
15.2. Company Profiles (Introduction, Financial Analysis, Key Products, Key Developments, Strategies, and SWOT Analysis) |
15.2.1. Thermo Fisher Scientific, inc. |
15.2.2. F. Hoffmann-La Roche Ltd. |
15.2.3. Danaher |
15.2.4. Quest Diagnostics |
15.2.5. Siemens Healthineers AG |
15.2.6. Abbott |
15.2.7. Merck KGaAA |
15.2.8. Zoetis |
15.2.9. Ortho Clinical Diagnostics |
15.2.10. Getein Biotech, Inc. |
15.2.11. HORIBA, Ltd |
15.2.12. Randox Laboratories Ltd. |
16. Research Methodology |
17. Key Assumptions and Acronyms |
Key Market Players